NL-OMON44369已完成不适用
Clinical validation of a dried blood spot (DBS) method for the analysis of immunosuppressive and antifungal drugs in pediatric patients (part of the PROTECT study). - PROTECT
Afdeling Apotheek0 个研究点目标入组 89 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 89
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 17（—）
入选标准
- •Patients aged between 2 and 18 years
- •Admitted to the pediatric ward or visiting the doctor on an outpatient basis
- •Having a venous catheter or blood is drawn for regular patient care
- •Treated with at least 1 of the 9 drugs of interest
- •Signed informed consent
排除标准
- •Parents and/or patients are not able to understand the Dutch language
研究者
相似试验
撤回
不适用
Clinical validation of a dried blood spot (DBS) method for the analysis of rifampicin (RIBOD study).analysis of drugs used for tuberculosis10004018NL-OMON42070niversitair Medisch Centrum Sint Radboud10
已完成
不适用
Clinical validation of the Dry Blood Spot (DBS) method for risperidone, aripiprazole, pipamperone and its major metabolitesnvt10013511NL-OMON45799Erasmus MC, Universitair Medisch Centrum Rotterdam120
已完成
不适用
Clinical validation of the Dry Blood Spot (DBS) method for risperidone, aripiprazole, pipamperone and its major metabolitesantipsychotics, pipamperone, aripiprazole, paliperidone, risperidoneNL-OMON28955Erasmus MC Medical Center60
已完成
不适用
Clinical validation of the dried blood spot analysis for antituberculosis drugsBlood concentration of anti TB drugs10028440NL-OMON34891niversitair Medisch Centrum Groningen33
招募中
不适用
Clinical evaluation of dried blood spots for the determination of ribociclib blood levelsAdvanced breast cancerNL-OMON25336ovartis20